Medipal Holdings Corp
TSE:7459

Watchlist Manager
Medipal Holdings Corp Logo
Medipal Holdings Corp
TSE:7459
Watchlist
Price: 2 880.5 JPY 0.93% Market Closed
Market Cap: ¥596.2B

Net Margin

1.1%
Current
Declining
by 0.1%
vs 3-y average of 1.2%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
1.1%
=
Net Income
¥40.6B
/
Revenue
¥3.7T

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
1.1%
=
Net Income
¥40.6B
/
Revenue
¥3.7T

Peer Comparison

Country Company Market Cap Net
Margin
JP
Medipal Holdings Corp
TSE:7459
591.5B JPY
Loading...
US
Mckesson Corp
NYSE:MCK
120.3B USD
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
70.3B USD
Loading...
US
Cencora Inc
NYSE:COR
68.5B USD
Loading...
US
Cardinal Health Inc
NYSE:CAH
53.6B USD
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
36.1B AUD
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
64.2B CNY
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
64.8B CNY
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
9.2B USD
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
66.3B HKD
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...

Market Distribution

Lower than 83% of companies in Japan
Percentile
17th
Based on 6 917 companies
17th percentile
1.1%
Low
-122 700% — 2.9%
Typical Range
2.9% — 8.5%
High
8.5% — 63 031.4%
Distribution Statistics
Japan
Min -122 700%
30th Percentile 2.9%
Median 5.4%
70th Percentile 8.5%
Max 63 031.4%

Medipal Holdings Corp
Glance View

Market Cap
596.2B JPY
Industry
Health Care

Medipal Holdings Corp., a longstanding pillar in Japan’s healthcare and pharmaceutical distribution network, tells a story of efficiency and dedication to health. Born from a strategic merger in the late 20th century, Medipal has established itself as a key player in the intricate world of pharmaceutical and medical supply logistics. The company's operations are woven into the fabric of Japan’s healthcare infrastructure, where precision and reliability form the foundation of its success. By orchestrating the smooth flow of pharmaceuticals, medical devices, and health-related products from manufacturers to a myriad of healthcare facilities and retail outlets, Medipal plays a vital role in ensuring that medical professionals and patients alike have timely access to necessary products. At the heart of Medipal's business model is a comprehensive supply chain that seamlessly connects an extensive network of partners. With sophisticated distribution centers operating as logistical powerhouses, Medipal leverages cutting-edge technology to optimize inventory management and delivery systems. This enables the company not only to drive efficiencies but also to create value by reducing costs and enhancing the speed and reliability of distributions. Revenue streams are generated primarily through distribution fees and the strategic management of logistics services. As Medipal continues to expand its reach and refine its operations, it remains steadfast in its commitment to being an indispensable ally in Japan's healthcare landscape, where reliability and trust are of paramount importance.

Intrinsic Value
7 825.74 JPY
Undervaluation 63%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
1.1%
=
Net Income
¥40.6B
/
Revenue
¥3.7T
What is Medipal Holdings Corp's current Net Margin?

The current Net Margin for Medipal Holdings Corp is 1.1%, which is below its 3-year median of 1.2%.

How has Net Margin changed over time?

Over the last 3 years, Medipal Holdings Corp’s Net Margin has increased from 0.8% to 1.1%. During this period, it reached a low of 0.8% on Sep 30, 2022 and a high of 1.4% on Dec 31, 2024.

Back to Top